Fetal or neonatal low-glycotoxin environment prevents autoimmune diabetes in NOD mice

Diabetes

Volumn 52, Issue 6, 2003, Pages 1441-1448

  Peppa, Melpomeni ^a   He, Cijiang ^a   Hattori, Masakazu ^b   McEvoy, Robert ^a   Zheng, Feng ^a   Vlassara, Helen ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 N CARBOXYMETHYLLYSINE; ADVANCED GLYCATION END PRODUCT; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; METHYLGLYOXAL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGENICITY; ARTICLE; AUTOIMMUNE DISEASE; CELL DAMAGE; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; ENVIRONMENTAL EXPOSURE; FEMALE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESPONSE; INSULITIS; MOUSE; NONHUMAN; NUTRITION; ONSET AGE; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL; T LYMPHOCYTE;

ADMINISTRATION, ORAL; AGING; ALBUMINURIA; ANIMALS; ANIMALS, NEWBORN; BLOOD GLUCOSE; CREATININE; CROSSES, GENETIC; DIABETES MELLITUS, TYPE 1; FEMALE; GLYCOSYLATION END PRODUCTS, ADVANCED; ISLETS OF LANGERHANS; LYSINE; MALE; MICE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PYRUVALDEHYDE;

EID: 0038659947     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.52.6.1441     Document Type: Article

References (50)

1. Haskins K, Portas M, Bergman B, Lafferty K, Bradley B: Pancreatic-islet specific T-cell clones from nonobese diabetic mice. Proc Natl Acad Sci U S A 86:8000-8004, 1989
2. Hawa MI, Beyan H, Buckley LR, Leslie RD: Impact of genetic and non-genetic factors in type 1 diabetes. Am J Med Genet 115:8-17, 2002
3. Hattori M, Buse JB, Jackson RA, Glimccher L, Dorf ME, Minami M, Makino S, Moriwaki K, Kuzuya H, Imura H: The NOD mouse: recessive diabetogenic gene in the major histocompatibility complex. Science 231:733-735, 1986
4. Kaufman DL, Tisch R, Sarvetnick N, Chatenoud L, Harrison LC, Haskins K, Quinn A, Sercarz E, Singh B, von Herrath M, Wegmann D, Wen L, Zekzer D: Report from the First International NOD Mouse T-Cell Workshop and the follow-up mini-workshop. Diabetes 50:2459-2463, 2001
5. Yoon JW, Yoon CS, Lim HW, Huang QQ, Kang Y, Pyun KH, Hirasawa K, Sherwin RS, Jun HS: Control of autoimmune diabetes in NOD mice by GAD expression or suppression in beta cells. Science 284:1183-1187, 1999
6. Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment. Lancet 358:221-229, 2001
7. Mathis D, Vence L, Benoist C: beta-Cell death during progression to diabetes. Nature 414:792-798, 2001
8. Linn T, Strate C, Schneider K: Diet promotes β-cell loss by apoptosis in prediabetic nonobese diabetic mice. Endocrinology 140:3767-3773, 1999
9. Hoorfar J, Buschard K, Dagnaes-Hansen F: Prophylactic nutritional modification of diabetes in autoimmune non-obese diabetic (NOD) mice. Br J Nutr 69:597-560, 1993
10. Scott FW, Cloutier HE, Kleemann R, Woerz-Pagenstert U, Rowsell P, Modler HW, Kolb H: Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells. Diabetes 46:589-598, 1997
11. Beales PE, Elliott RB, Flohe S, Hill JP, Kolb H, Pozzilli P, Wang GS, Wasmuth H, Scott FW: A multi-center, blinded international trial of the effect of A(1) and A(2) beta-casein variants on diabetes incidence in two rodent models of spontaneous type I diabetes. Diabetologia 45:1240-1246, 2002
12. Scott FW, Rowsell P: Controlling diabetes in the BB rat by modifying exposure to food diabetogens: age at first exposure, dietary dose, and effects of early intrathymic or oral dosing. Autoimmunity 21:21-22, 1995
13. Funda DP, Kaas A, Bock T, Tlaskalova-Hogenova H, Buchard K: Gluten-free diet prevents diabetes in NOD mice. Diabete Metab Res Rev 15:323-327, 1999
14. Benhamou PY, Mullen Y, Clare-Salzler M, Sangkharat A, Benhamou C, Shevlin L, Go VL: Essential fatty acid deficiency prevents autoimmune diabetes in nonbese diabetic mice through a positive impact on antigen-presenting cells and Th2 lymphocytes. Pancreas 11:26-37, 1995
15. Vlassara H, Palace MR: Diabetes and advanced glycation endproducts. J Intern Med 251:87-101, 2002
16. Baynes JW: The Maillard hypothesis on aging: time to focus on DNA. Ann N Y Acad Sci 959:360-367, 2002
17. Kaneto H, Fujii J, Myint T, Miyazawa N, Islam KN, Kawasaki Y, Suzuki K, Nakamura M, Tatsumi H, Yamasaki Y, Taniguchi N: Reducing sugars trigger oxidative modification and apoptosis in pancreatic β-cells by provoking oxidative stress through the glycation reaction. Biochem J 320:855-863, 1996
18. Kapurniotu A, Bernhagen J, Greenfield N, Al-Abed Y, Teichberg S, Frank RW, Voelter W, Bucala R: Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide. Eur J Biochem 251:208-216, 1998
19. Thornalley PJ: Cell activation by glycated proteins: AGE receptors, receptor recognition factors and functional classification of AGEs. Cell Mol Biol (Noisy-le-grand) 44:1013-1023, 1998
20. Ivanov GI, Chaushev TA, Dakovska LN, Kyurkchiev SD: Increased adhesion of lymphoid cells to glycated proteins. Int J Biochem Cell Biol 31:797-804, 1999
21. Imani F, Horii Y, Suthanthiran M, Skolnik EY, Makita Z, Sharma V, Sehajpal P, Vlassara H: Advanced glycosylation endproduct-specific receptors on human and rat T-lymphocytes mediate synthesis of interferon gamma: role in tissue remodeling. J Exp Med 178:2165-2172, 1993
22. Lee T, Kimiagar M, Pintauro SJ, Chichester CO: Physiological and safety aspects of Maillard browning of foods. Prog Food Nutr Sci 5:243-256, 1981
23. O'Brien J, Morrissey PA: Nutritional and toxicological aspects of the Maillard browning reaction in foods. Crit Rev Food Sci Nutr 28:211-248, 1989
24. Pellegrino L, Cattaneo S: Occurrence of galactosyl isomaltol and galactosyl beta-pyranone in commercial drinking milk. Nahrung 45:195-200, 2001
25. Koschinsky T, He CJ, Mitsuhashi T, Bucala R, Liu C, Buenting C, Heitmann K, Vlassara H: Orally absorbed reactive advanced glycation end products (glycotoxins): an environmental risk factor in diabetic nephropathy. Proc Natl Acad Sci U S A 94:6474-6479, 1997
26. He C, Sabol J, Mitsuhashi T, Vlassara H: Dietary glycotoxins: Inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes 48:1308-1315, 1999
27. Peppa M, Zhang JG, Cai W, Brem H, Vlassara H: In vivo glycoxidation product homeostasis depends on dietary input, under stable hyperglycemia (Abstract). Diabetes 51 (Suppl. 2):332A, 2002
28. Zheng F, He C, Cai W, Hattori M, Steffes M, Vlassara H: Prevention of diabetic nephropathy in mice by a diet low in glycoxidation products. Diabete Metab Res Rev 18:224-237, 2002
29. Lin RY, Reis ED, Dore AT, Lu M, Ghodsi N, Fallon JT, Fisher EA, Vlassara H: Lowering of dietary advanced glycation endproducts (AGE) reduces neointimal formation after arterial injury in genetically hypercholesterolemic mice. Arterioscler Thromb Vasc Biol Atherosclerosis 163:303-311, 2002
30. (+/+) mice is regulated by dietary content in glycotoxins under stable hyperglycemia (Abstract). Diabetes 51 (Suppl. 2):17A, 2002
31. Hofmann SM, Dong HJ, Li Z, Cai W, Altomonte J, Thung SN, Zeng F, Fisher EA, Vlassara H: Improved insulin sensitivity is associated with restricted intake of dietary glycoxidation products in the db/db mouse. Diabetes 51:2082-2089, 2002
32. Lin R, Chuodhury R, Lu M, Dore A, Fallon J, Fisher E, Vlassara H: Supression of atherosclerotic lesions by dietary restriction of advanced glycation end products (AGEs) in diabetic apolipoprotein E-deficient C57BL/6J mice. Atherosclerosis. In press
33. Vlassara H, Cai W, Crandall J, Goldberg T, Oberstein R, Dardaine V, Peppa M, Rayfield E: Inflammatory: mediators are induced by dietary glycotoxins, a major risk factor for diabetic angiopathy. Proc Natl Acad Sci U S A 99:15596-15601, 2002
34. Tajiri Y, Moller C, Grill V: Long term effects of aminoguanidine on insulin release and biosynthesis: evidence that the formation of advanced glycosylation end products inhibits β cell function. Endocrinology 138:273-280, 1997
35. Uribarri J, Peppa M, Cai W, Goldberg T, Lu M, He C, Vlassara H: Restriction of dietary glycotoxins markedly reduces AGE toxins in renal failure patients. J Am Soc Nephrol 14:728-731, 2003
36. Cai W, Cao Q, Zhu L, Peppa M, He C, Vlassara H: Oxidative stress-inducing carbonyl compounds from common foods: novel mediators of cellular dysfunction. Molecular Medicine 8:337-346, 2002
37. Mellinghoff AC, Reininger AJ, Wuerth JP, Founds HW, Landgraf R, Hepp KD: Formation of plasma advanced glycosylation end products (AGEs) has no influence on plasma viscosity. Diabet Med 14:832-836, 1997
38. The National Academy of Sciences: Nutrient Requirements of Laboratory Animals. Washington, DC, National Academy Press 1995
39. Hattori M, Fukuda M, Ichikawa T, Baumgartl HJ, Katoh H, Makino S: A single recessive non-MHC diabetogenic gene determines the development of insulitis in the presence of an MHC-linked diabetogenic gene in NOD mice. J Autoimmun 3:1-10, 1990
40. Radu DL, Brumeanu TD, McEvoy RC, Bona CA, Casares S: Escape from self-tolerance leads to neonatal insulin-dependent diabetes mellitus. Autoimmunity 30:199-207, 1999
41. Rabinovitch A, Suarez-Pinzon W, El-Sheikh A, Sorensen O, Power RF: Cytokine gene expression in pancreatic islet-infiltrating leukocytes of BB rats: expression of Th1 cytokines correlates with beta-cell destructive insulitis and IDDM. Diabetes 45:749-754, 1996
42. Charre S, Rosmalen JG, Pelegri C, Alves V, Leenen PJ, Drexhage HA, Homo-Delarche F: Abnormalities in dendritic cell and macrophage accumulation in the pancreas of nonobese diabetic (NOD) mice during the early neonatal period. Histol Histopathol 17:393-401, 2002
43. Pelegri C, Rosmalen JG, Durant S, Throsby M, Alves V, Coulaud J, Esling A, Pleau JM, Drexhage HA, Homo-Delarche F: Islet endocrine-cell behavior from birth onward in mice with the nonobese diabetic genetic background. Mol Med 7:311-319, 2001
44. Monetini L, Cavallo MG, Stefanini L, Ferrazzoli F, Bizzarri C, Marietti G, Curro V, Cervoni M, Pozzilli P, IMDIAB Group: Bovine beta-casein antibodies in breast- and bottle-fed infants: their relevance in type 1 diabetes. Diabete Metab Res Rev 17:51-54, 2001
45. Scott FW, Rowsell P, Wang GS, Burghardt K, Kolb H, Flohe S: Oral exposure to diabetes-promoting food or immunomodulators in neonates alters gut cytokines and diabetes. Diabetes 51:73-78, 2002
46. Vaarala O: Gut and the induction of immune tolerance in type 1 diabetes. Diabete Metab Res Rev 15:353-361, 1999
47. Mosmann TR, Coffman RL: Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173, 1989
48. Ma SW, Zhao DL, Yin ZQ, Mukherjee R, Singh B, Qin HY, Stiller CR, Jevnikar AM: Transgenic plants expressing autoantigens fed to mice to induce oral immune tolerance. Nat Med 3:793-796, 1997
49. Akama K, Akihiro T, Kitagawa M, Takaiwa F: Rice (Oryza sativa) contains a novel isoform of glutamate decarboxylase that lacks an authentic calmodulin-binding domain at the C-terminus. Biochim Biophys Acta 1522:143-150, 2001
50. Laron Z: Interplay between heredity and environment in the recent explosion of type 1 childhood diabetes mellitus. Am J Med Genet 115:4-7, 2002